Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000934628 | SCV001080355 | benign | Mucopolysaccharidosis, MPS-II | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002427322 | SCV002731508 | likely benign | Inborn genetic diseases | 2022-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004597927 | SCV005093305 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | IDS: BS2 |
Natera, |
RCV000934628 | SCV001466678 | likely benign | Mucopolysaccharidosis, MPS-II | 2020-10-12 | no assertion criteria provided | clinical testing |